Skip to main navigation Skip to search Skip to main content

Latent Tuberculosis Infection Screening and Treatment in Congregate Settings (TB FREE COREA): Demographic Profiles of Interferon-Gamma Release Assay Cohort

  • The Catholic University of Korea Incheon St. Mary's Hospital
  • Catholic Univ. of Korea Coll. Med.
  • Korea National Institute of Health
  • Inje University
  • Dankook University

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

In 2017, the Korean government launched an unprecedentedly large-scaled latent tuberculosis infection (LTBI) screening project which covered more than a million individuals in congregate settings. A total of 1,047,689 participants out of source population (n = 2,336,157) underwent LTBI testing from 2017 to 2018. The overall LTBI test uptake rate during this project was 44.8%. Workers in daycare centers (83.5%) and kindergartens (78.9%) showed high participation rate. A total of 1,012,206 individuals with valid results of interferon-gamma release assay (IGRA) were selected to constitute the IGRA cohort. Most of the enrolled participants in the IGRA cohort were of working age. Approximately, three-quarters of total enrolled population were female. Investigating the LTBI prevalence, stages of LTBI care cascade, natural history of LTBI, efficacy of LTBI treatment and cost-effectiveness of LTBI screening are feasible within this IGRA cohort.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalJournal of Korean Medical Science
Volume36
Issue number36
DOIs
StatePublished - 2021

Bibliographical note

Publisher Copyright:
© 2021 The Korean Academy of Medical Sciences.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Interferon-gamma Release Tests
  • Latent Tuberculosis
  • Mass Screening
  • Republic of Korea

Fingerprint

Dive into the research topics of 'Latent Tuberculosis Infection Screening and Treatment in Congregate Settings (TB FREE COREA): Demographic Profiles of Interferon-Gamma Release Assay Cohort'. Together they form a unique fingerprint.

Cite this